Theravance Biopharma (TBPH) Net Margin Growth (1y) (2014 - 2026)
Theravance Biopharma (TBPH) Net Margin Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Theravance Biopharma |
835.85 Mn |
441.18 Mn |
- |
6,016.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
6,016.00 |
| Dec 31, 2025 |
-36,103.00 |
| Sep 30, 2025 |
9,334.00 |
| Jun 30, 2025 |
32,528.00 |
| Mar 31, 2025 |
-782.00 |
| Dec 31, 2024 |
17,377.00 |
| Sep 30, 2024 |
-1,825.00 |
| Jun 30, 2024 |
-215.00 |
| Mar 31, 2024 |
13,161.00 |
| Dec 31, 2023 |
-7,489.00 |
| Sep 30, 2023 |
-750,295.00 |
| Jun 30, 2023 |
-28,012.00 |
| Mar 31, 2023 |
-83,572.00 |
| Dec 31, 2022 |
-14,591.00 |
| Sep 30, 2022 |
728,977.00 |
| Jun 30, 2022 |
6,991.00 |
| Mar 31, 2022 |
57,591.00 |
| Dec 31, 2021 |
57,430.00 |
| Sep 30, 2021 |
55,952.00 |
| Jun 30, 2021 |
51,544.00 |
